Narrow your search by using the search box and/or filters to the left.
Children’s Healthcare of Atlanta and Emory University Hospital participated in a nationwide four-day, large-scale patient movement exercise that involved more than 50 international, federal, state and local collaborators, designed to test and validate the nation’s ability to move patients with highly infectious diseases safely and securely to regional treatment centers. Children’s Arthur M. Blank Hospital and Emory University Hospital, a part of Emory Healthcare, are a combined Regional Emerging Special Pathogen Treatment Center and one of 13 in the county with specialized training and capabilities to care for patients with highly contagious infectious diseases.
Center for Childhood Infections and Vaccines (CCIV)
Congratulations to Lisa Marie Cranmer, MD, MPH, for receiving the 2025 Passionate Provider Award in recognition for her work to develop and implement a breastfeeding support program at Grady, benefitting numerous women living with HIV at the Emory Center for AIDS Research (CFAR)’s 8th Annual Barbara Vick Impact Awards on Thursday, May 29, 2025. The event is hosted by the CFAR’s Community Liaison Council to celebrate local “unsung heroes” – nurses, clinicians, community advocates, researchers, public health workers – who are making a difference in the Metro-Atlanta HIV response. This year, the awards ceremony recognized 23 honorees, including Dr. Cranmer (Associate Professor, Department of Pediatrics, Division of Infectious Diseases, SOM).
Center for Childhood Infections and Vaccines (CCIV)
New cystic fibrosis drug allows more patients to breathe easier: Children’s Healthcare of Atlanta patients and doctors were part of studies for a new drug, Alyftrek.
From the Atlanta Journal-Constitution, originally published here on June 16, 2025.
Winners Announced at the 14th Annual Southeastern Pediatric Research Conference
The 14th Annual Southeastern Pediatric Research Conference, held on Friday, June 6th at the Georgia Aquarium, celebrated excellence in pediatric research with record attendance and outstanding presentations from across the region. We are excited to announce this year’s award winners:
Best Poster Presentation: Coco Zheng (Emory University)
Poster Runner-Up: Sean Stielow, MS, MAT, BS (Emory University)
Best Rapid-Fire Presentation: Samadhi Attanayaka (Georgia Institute of Technology)
Rapid-Fire Runner-Up: Erin Seibel, MMSc, LCGC (Emory University)
Congratulations to all of our winners for their exceptional contributions and thank you to all who participated in making this year’s conference a success. We look forward to seeing you next year!
Researchers from Winship Cancer Institute of Emory University and the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta have published the most comprehensive single-cell analysis of pediatric leukemia to date in Nature Communications. The study introduces the Pediatric Single-cell Cancer Atlas (PedSCAtlas), the first public online resource of its kind dedicated to pediatric cancers.
Aflac Cancer and Blood Disorders Center (Aflac)
A new paper published in Proceedings of the National Academy of Sciences (PNAS) shows promising results that the fingernail photo is just as accurate at screening and monitoring anemia as a blood sample. In real-world use across the U.S., the app amassed over 1.4 million uses of the tool. For users who compared their app results with blood tests, the app demonstrated strong performance — achieving 89% sensitivity and 93% specificity for anemia detection. “From early signs of anemia to tracking trends that could help with life-threatening hemoglobin level drops, a photo of the fingernail was shown to be extremely accurate,” says Wilbur Lam, senior author on the paper, and professor at Emory University and Georgia Tech. “What makes the technology even more powerful is the AI-powered algorithm that automatically ‘zooms in’ on the fingernails of the photo the user just took and enables a more personalized medicine approach.”
Aflac Cancer and Blood Disorders Center (Aflac)
A recent study of cystic fibrosis (CF) infants and toddlers, conducted by a multinational team of researchers including several from the Center for Cystic Fibrosis and Airways Disease Research (CF-AIR), has revealed potential metabolite biomarkers for monitoring and evaluating risk of lung disease in early life CF.
“Early life elevations of methionine oxidation and ornithine track and predict cystic fibrosis structural lung disease" was published in European Respiratory Journal Open Research on March 25, 2025, with Joshua Chandler, PhD, an Emory University Assistant Professor and the incoming Scientific Director of the Pediatric Metabolomics and Biomarkers Core (PMBC), as the corresponding author.
Center for Cystic Fibrosis and Airways Disease Research (CF-AIR)
Raymond Schinazi, PhD, Frank Amblard, PhD, and Leda Bassit, PhD were awarded Start-Up of the Year on April 17, 2025, at the 40 year-celebration ceremony of the Emory University Office of Technology Transfer for their start-up, Aligos Therapeutics. Aligos Therapeutics is a clinical-stage biotechnology company founded with the mission to improve patient outcomes by developing best-in-class therapies.
Center for ViroScience and Cure (CVC)
Atlanta’s Marcus Autism Center is studying root causes of elopement, or running away from supervision, among children with autism — and what caretakers can do to make wandering less likely. Marcus Autism Center conducted the largest study yet of the risks of elopement, or wandering, among children with autism and what caretakers can do to mitigate those risks. Click here for the GPB article and interview with the study's first author, Mindy Scheithauer, PhD, BCBA-D. Link to this study can be found here.
Marcus Autism Center
The cores administrative team is thrilled to announce that the Biomarkers Core will re-launch as the Pediatric Metabolomics and Biomarkers Core. Under Dr. Joshua Chandler's leadership, the PMBC will offer multiple new services, including polytargeted metabolomics, isotope tracing, and high-resolution MS imaging. The new core and services are expected to begin operating in summer 2025.
